Lixa was established in 2021 with a focus on developing scalable antibiofilm technologies to treat antimicrobial resistance (AMR).
In 2022, Lixa won the Wesfarmers award for its Neo X platform technology at the WA Innovator of the Year Awards.
| NEW ROLE: Aaron Brinkworth, Non-Executive Director | 17 Dec 2025 | |
| NEW ROLE: Mark Pitts, Chief Financial Officer | 17 Dec 2025 | |
|
NEW ROLE: Craig Breen, Chief Operating Officer | 17 Dec 2025 |
| NEW ROLE: Aled Miles, Non-Executive Director | 17 Dec 2025 | |
| NEW ROLE: Brett Rowe, Non-Executive Director | 17 Dec 2025 | |
| NEW ROLE: John Poynton, Chair | 17 Dec 2025 | |
|
NEWS: Tagged in Lixa assembles AMR avengers | 14 Feb 2025 |
|
NEWS: Tagged in Appointments February 14, 2025 | 13 Feb 2025 |
|
NEWS: Tagged in Lixa move NeoX-101 to clinical trials | 18 Nov 2024 |
|
NEWS: Tagged in Bridging WA's Innovation to Commercialisation Gap | 09 Sep 2024 |